RR
Ravi Ranjan
About Ravi Ranjan
Data last updated:
Ravi Ranjan is an Additional Director at Healthtron Private Limited (since 2024) and Director at Aarxkey Pharma Private Limited (since 2025). The companies operate in Information Technology. The largest current company by reported revenue is Healthtron Private Limited at ₹45.2 Lakh (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Healthtron Private Limited U51909WB2021PTC246853 | Additional Director | 17 Oct 2024 | 2021 | ₹45.2 Lakh (FY 2024) | Active |
| Aarxkey Pharma Private Limited U47721HR2025PTC129043 | Director | 27 Feb 2025 | 2025 | Active |
Board colleagues of Ravi Ranjan
| Name | DIN | Company | Designation |
|---|---|---|---|
| Pradeep Kumar | 10812152 | Healthtron Private Limited , Aarxkey Pharma Private Limited | Additional Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ravi Ranjan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ravi Ranjan
Ravi Ranjan currently holds 2 directorships: Healthtron Private Limited (Additional Director, since 17 Oct 2024, revenue ₹45.2 Lakh (FY 2024)); Aarxkey Pharma Private Limited (Director, since 27 Feb 2025).
Ravi Ranjan was first appointed on 17 Oct 2024 as Additional Director at Healthtron Private Limited. The most recent appointment on record is 27 Feb 2025 at Aarxkey Pharma Private Limited.
The current boards of Ravi Ranjan's companies include Pradeep Kumar (Healthtron Private Limited).